Transfusion Rates in Total Hip Replacement Before/After the Implementation of a Patient Blood Management Program.

Change in Transfusion Rates of Patients Undergoing Elective Total Hip Replacement Before/After the Implementation of a Peri-operative Patient Blood Management Program: a Retrospective Observational Study.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04398238

Acronym

pbm-hip

Enrollment

400

Registered

2020-05-21

Start date

2021-08-01

Completion date

2023-04-04

Last updated

2023-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia (Diagnosis), Arthroplasty, Iron-deficiency, Transfusion

Keywords

patient blood management, anemia, Arthroplasty

Brief summary

Retrospective observational study: impact of a peri-operative patient blood management program (PBM) on transfusion rates of patients undergoing elective hip replacement.

Detailed description

A Patient Blood Management (PBM) program was implemented in year 2019 in our institution: patient scheduled for elective total hip replacement underwent pre-operative screening about one month before surgery, and those with pre-operative hemoglobin \< 13 g/dl were screened for possible causes and treatment of anemia. Data from two different time frames, before and after the implementation of the program, were collected to study the change in clinical outcomes such as transfusion rates, length of stay, etc.

Interventions

COMBINATION_PRODUCTevaluation by transfusion medicine specialist

screening for anemia causes and treatment: iron/folate/vitamin B12 supplementation, Erythropoietin administration if indicated

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* undergoing elective hip replacement in the selected time-frame * American Society of Anesthesiology (ASA) status 1-2-3 * age \>18

Exclusion criteria

* patients not undergoing screening as outpatients at pre-operative clinic

Design outcomes

Primary

Measure	Time frame	Description
transfusion rates	from day of surgery till day of discharge, up to 60 days	percentage of patients undergoing hip replacement who receive at least one unit of concentrated red cells during or after surgery

Secondary

Measure	Time frame	Description
minimum hemoglobin	from day of surgery till day of discharge, up to 60 days	minimum hemoglobin reached after surgery
hemoglobin at discharge	from day of surgery till day of discharge, up to 60 days	last measured hemoglobin before discharge from hospital
length of stay	from day of surgery till day of discharge, up to 60 days	total days of hospital stay from admission to discharge

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026